Neurogene Inc. (NGNE)
NASDAQ: NGNE · Real-Time Price · USD
15.33
-1.90 (-11.03%)
At close: Nov 20, 2024, 4:00 PM
15.05
-0.28 (-1.83%)
Pre-market: Nov 21, 2024, 7:16 AM EST
Neurogene Market Cap
Neurogene has a market cap or net worth of $199.19 million as of November 21, 2024. Its market cap has increased by 561.77% in one year.
Market Cap
199.19M
Enterprise Value
73.32M
1-Year Change
561.77%
Ranking
Category
Stock Price
$15.33
Market Cap Chart
Since March 7, 2014, Neurogene's market cap has increased from $114.10M to $199.19M, an increase of 74.58%. That is a compound annual growth rate of 5.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 255.90M | 462.42% |
| Dec 29, 2023 | 45.50M | 109.68% |
| Dec 30, 2022 | 21.70M | -89.39% |
| Dec 31, 2021 | 204.50M | -65.38% |
| Dec 31, 2020 | 590.70M | 25.07% |
| Dec 31, 2019 | 472.30M | 829.72% |
| Dec 31, 2018 | 50.80M | -81.59% |
| Dec 29, 2017 | 275.90M | -28.65% |
| Dec 30, 2016 | 386.70M | 80.03% |
| Dec 31, 2015 | 214.80M | 167.83% |
| Dec 31, 2014 | 80.20M | -29.71% |
| Mar 7, 2014 | 114.10M | - |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ocugen | 265.45M |
| Mersana Therapeutics | 260.65M |
| Poseida Therapeutics | 260.23M |
| Eton Pharmaceuticals | 259.14M |
| Fate Therapeutics | 258.54M |
| Abeona Therapeutics | 255.24M |
| Artiva Biotherapeutics | 250.42M |
| Anika Therapeutics | 249.56M |